NCT05347069View on ClinicalTrials.gov

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,890

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

March 31, 2030

Study Completion Date

December 31, 2030

Conditions
Stable Angina PectorisCoronary Artery DiseaseIschemic Heart Disease
Interventions
DRUG

Aspirin

Aspirin 100 mg/day

DRUG

No aspirin

No aspirin administered

Trial Locations (1)

Unknown

RECRUITING

Kyoto University Hospital, Kyoto

All Listed Sponsors
lead

Takeshi Morimoto

OTHER

NCT05347069 - Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization | Biotech Hunter | Biotech Hunter